245 related articles for article (PubMed ID: 8393676)
1. Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy.
Barrera P; Boerbooms AM; Janssen EM; Sauerwein RW; Gallati H; Mulder J; de Boo T; Demacker PN; van de Putte LB; van der Meer JW
Arthritis Rheum; 1993 Aug; 36(8):1070-9. PubMed ID: 8393676
[TBL] [Abstract][Full Text] [Related]
2. Effect of methotrexate alone or in combination with sulphasalazine on the production and circulating concentrations of cytokines and their antagonists. Longitudinal evaluation in patients with rheumatoid arthritis.
Barrera P; Haagsma CJ; Boerbooms AM; Van Riel PL; Borm GF; Van de Putte LB; Van der Meer JW
Br J Rheumatol; 1995 Aug; 34(8):747-55. PubMed ID: 7551660
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
Seitz M; Zwicker M; Villiger PM
J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
[TBL] [Abstract][Full Text] [Related]
4. Interleukin 1 (IL-1) receptor antagonist, soluble tumor necrosis factor receptors, IL-1 beta, and IL-8--markers of remission in rheumatoid arthritis during treatment with methotrexate.
Seitz M; Loetscher P; Dewald B; Towbin H; Rordorf C; Gallati H; Gerber NJ
J Rheumatol; 1996 Sep; 23(9):1512-6. PubMed ID: 8877917
[TBL] [Abstract][Full Text] [Related]
5. Serum cytokines in juvenile rheumatoid arthritis. Correlation with conventional inflammation parameters and clinical subtypes.
Mangge H; Kenzian H; Gallistl S; Neuwirth G; Liebmann P; Kaulfersch W; Beaufort F; Muntean W; Schauenstein K
Arthritis Rheum; 1995 Feb; 38(2):211-20. PubMed ID: 7848311
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 6 (IL-6) and soluble IL-2 receptor levels in patients with rheumatoid arthritis treated with low dose oral methotrexate.
Crilly A; McInness IB; McDonald AG; Watson J; Capell HA; Madhok R
J Rheumatol; 1995 Feb; 22(2):224-6. PubMed ID: 7738942
[TBL] [Abstract][Full Text] [Related]
7. The effect of azathioprine on serum levels of interleukin 6 and soluble interleukin 2 receptor.
Crilly A; McInnes IB; Capell HA; Madhok R
Scand J Rheumatol; 1994; 23(2):87-91. PubMed ID: 8165444
[TBL] [Abstract][Full Text] [Related]
8. Interference of circulating azathioprine but not methotrexate or sulfasalazine with measurements of interleukin-6 bioactivity.
Barrera P; Boerbooms AM; Sauerwein RW; Demacker PN; van de Putte LB; van der Meer JW
Lymphokine Cytokine Res; 1994 Apr; 13(2):155-9. PubMed ID: 7914751
[TBL] [Abstract][Full Text] [Related]
9. Increased levels of soluble tumor necrosis factor receptors in the sera and synovial fluid of patients with rheumatic diseases.
Cope AP; Aderka D; Doherty M; Engelmann H; Gibbons D; Jones AC; Brennan FM; Maini RN; Wallach D; Feldmann M
Arthritis Rheum; 1992 Oct; 35(10):1160-9. PubMed ID: 1329774
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate action in rheumatoid arthritis: stimulation of cytokine inhibitor and inhibition of chemokine production by peripheral blood mononuclear cells.
Seitz M; Loetscher P; Dewald B; Towbin H; Rordorf C; Gallati H; Baggiolini M; Gerber NJ
Br J Rheumatol; 1995 Jul; 34(7):602-9. PubMed ID: 7670776
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumour necrosis factor-alpha bioactivity in rheumatoid arthritis patients treated with infliximab: link to clinical response.
Marotte H; Maslinski W; Miossec P
Arthritis Res Ther; 2005; 7(1):R149-55. PubMed ID: 15642135
[TBL] [Abstract][Full Text] [Related]
12. Soluble cytokine receptors and the low 3,5,3'-triiodothyronine syndrome in patients with nonthyroidal disease.
Boelen A; Platvoet-Ter Schiphorst MC; Wiersinga WM
J Clin Endocrinol Metab; 1995 Mar; 80(3):971-6. PubMed ID: 7883859
[TBL] [Abstract][Full Text] [Related]
13. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-2, soluble interleukin-2 receptor and tumor necrosis factor in sera from patients with rheumatoid arthritis.
Corvetta A; Luchetti MM; Pomponio G; Della Bitta R; Recchioni A; Strusi P; De Sio G; Danieli G
Ric Clin Lab; 1990; 20(4):275-81. PubMed ID: 2075380
[TBL] [Abstract][Full Text] [Related]
15. Circulating levels of cytokines and soluble cytokine receptors in various T-cell malignancies.
Raziuddin S; Sheikha A; Abu-Eshy S; al-Janadi M
Cancer; 1994 May; 73(9):2426-31. PubMed ID: 8168046
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-2 receptor levels in the sera of rheumatoid arthritis patients treated with methotrexate.
Polisson RP; Dooley MA; Dawson DV; Pisetsky DS
Arthritis Rheum; 1994 Jan; 37(1):50-6. PubMed ID: 8129764
[TBL] [Abstract][Full Text] [Related]
17. Serum soluble interleukin-2 receptor levels in rheumatoid arthritis: effect of methotrexate, sulphasalazine and hydroxychloroquine therapy.
Salaffi F; Carotti M; Cervini C
Clin Rheumatol; 1995 Jul; 14(4):458-63. PubMed ID: 7586985
[TBL] [Abstract][Full Text] [Related]
18. Interleukin (IL)-6, tumour necrosis factor alpha (TNF-α) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression.
Liu Y; Ho RC; Mak A
J Affect Disord; 2012 Aug; 139(3):230-9. PubMed ID: 21872339
[TBL] [Abstract][Full Text] [Related]
19. Interleukins and their antagonists but not TNF and its receptors are released in post-ERP pancreatitis.
Messmann H; Vogt W; Falk W; Vogl D; Zirngibl H; Leser HG; Schölmerich J
Eur J Gastroenterol Hepatol; 1998 Jul; 10(7):611-7. PubMed ID: 9855088
[TBL] [Abstract][Full Text] [Related]
20. Influence of corticosteroid pulse therapy on the serum levels of soluble interleukin 2 receptor, interleukin 6 and interleukin 8 in patients with rheumatoid arthritis.
van den Brink HR; van Wijk MJ; Geertzen RG; Bijlsma JW
J Rheumatol; 1994 Mar; 21(3):430-4. PubMed ID: 7911833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
